7 min read
The Long View: Big Pharma Is Growing Its Own Again
Organic drugs have climbed to 53% of the top 15's sales by 2025. The aggregate hides the more interesting split: which companies built the future they will sell, which bought it, and which are watching their homegrown base expire.
